Search Results - "Rabinovich, C Egla"

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series by Nigrovic, Peter A., Mannion, Melissa, Prince, Femke H. M., Zeft, Andrew, Rabinovich, C. Egla, van Rossum, Marion A. J., Cortis, Elisabetta, Pardeo, Manuela, Miettunen, Paivi M., Janow, Ginger, Birmingham, James, Eggebeen, Aaron, Janssen, Erin, Shulman, Andrew I., Son, Mary Beth, Hong, Sandy, Jones, Karla, Ilowite, Norman T., Cron, Randy Q., Higgins, Gloria C.

“…Objective To examine the safety and efficacy of the interleukin‐1 (IL‐1) receptor antagonist anakinra as first‐line therapy for systemic juvenile idiopathic…”
Get full text

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis–Associated and Idiopathic Chronic Anterior Uveitis by Angeles‐Han, Sheila T., Lo, Mindy S., Henderson, Lauren A., Lerman, Melissa A., Abramson, Leslie, Cooper, Ashley M., Parsa, Miriam F., Zemel, Lawrence S., Ronis, Tova, Beukelman, Timothy, Cox, Erika, Sen, H. Nida, Holland, Gary N., Brunner, Hermine I., Lasky, Andrew, Rabinovich, C. Egla

“…Objective Systemic immunosuppressive treatment of pediatric chronic anterior uveitis (CAU), both juvenile idiopathic arthritis–associated and idiopathic…”
Get full text

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features by Beukelman, Timothy, Patkar, Nivedita M., Saag, Kenneth G., Tolleson‐Rinehart, Sue, Cron, Randy Q., DeWitt, Esi Morgan, Ilowite, Norman T., Kimura, Yukiko, Laxer, Ronald M., Lovell, Daniel J., Martini, Alberto, Rabinovich, C. Egla, Ruperto, Nicolino

“…Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns…”
Get full text

Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma by Li, Suzanne C., Torok, Kathryn S., Pope, Elena, Dedeoglu, Fatma, Hong, Sandy, Jacobe, Heidi T., Rabinovich, C. Egla, Laxer, Ronald M., Higgins, Gloria C., Ferguson, Polly J., Lasky, Andrew, Baszis, Kevin, Becker, Mara, Campillo, Sarah, Cartwright, Victoria, Cidon, Michael, Inman, Christi J., Jerath, Rita, O'Neil, Kathleen M., Vora, Sheetal, Zeft, Andrew, Wallace, Carol A., Ilowite, Norman T., Fuhlbrigge, Robert C.

“…Objective Juvenile localized scleroderma (LS) is a chronic inflammatory skin disorder associated with substantial morbidity and disability. Although a wide…”
Get full text

TNXB Mutations Can Cause Vesicoureteral Reflux by GBADEGESIN, Rasheed A, BROPHY, Patrick D, WESTREICH, Katherine, GUANGHONG WU, YUTAO LIU, HOLANDA, Danniele, CLARKE, Jason, LAVIN, Peter, SELIM, Angelica, MILLER, Sara, WIENER, John S, ROSS, Sherry S, ADEYEMO, Adebowale, FOREMAN, John, ROTIMI, Charles, WINN, Michelle P, HALL, Gentzon, GUPTA, Indra R, HAINS, David, BARTKOWIAK, Bartlomeij, EGLA RABINOVICH, C, CHANDRASEKHARAPPA, Settara, HOMSTAD, Alison

“…Primary vesicoureteral reflux (VUR) is the most common congenital anomaly of the kidney and the urinary tract, and it is a major risk factor for pyelonephritic…”
Get full text

Methotrexate: New Uses for an Old Drug by Hashkes, Philip J., MD, MSc, Becker, Mara L., MD, MSCE, Cabral, David A., MBBS, Laxer, Ronald M., MD, FRCPC, Paller, Amy S., MD, MS, Rabinovich, C. Egla, MD, MPH, Turner, Dan, MD, PhD, Zulian, Francesco, MD

Get full text

The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures by ARKACHAISRI, Thaschawee, VILAIYUK, Soamarat, ROSEN, Paul, SPALDING, Steven J, HENNON, Teresa R, TOROK, Kathryn S, CASSIDY, Elaine, MEDSGER, Thomas A, SUZANNE LI, O'NEIL, Kathleen M, POPE, Elena, HIGGINS, Gloria C, PUNARO, Marilynn, RABINOVICH, Egla C, ROSENKRANZ, Margalit, KIETZ, Daniel A

“…Objective. To develop and evaluate a Localized Scleroderma (LS) Skin Severity Index (LoSSI) and global assessments’ clinimetric property and effect on…”
Get full text

Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis–associated uveitis: A consensus effort from the multinational interdisciplinary working group for uveitis in childhood by Heiligenhaus, Arnd, Foeldvari, Ivan, Edelsten, Clive, Smith, Justine R., Saurenmann, Rotraud K., Bodaghi, Bahram, de Boer, Joke, Graham, Elizabeth, Anton, Jordi, Kotaniemi, Kaisu, Mackensen, Friederike, Minden, Kirsten, Nielsen, Susan, Rabinovich, Egla C., Ramanan, Athimalaipet V., Strand, Vibeke

“…Objective To develop a set of core outcome measures for use in randomized controlled trials (RCTs) and longitudinal observational studies in juvenile…”
Get full text

Profile of adalimumab and its potential in the treatment of uveitis by Balevic, Stephen J, Rabinovich, C Egla

“…Uveitis refers to the presence of intraocular inflammation, and as a strict definition compromises the iris and ciliary body anteriorly and the choroid…”
Get full text

Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study by Li, Suzanne C, Fuhlbrigge, Robert C, Laxer, Ronald M, Pope, Elena, Ibarra, Maria F, Stewart, Katie, Mason, 2nd, Thomas, Becker, Mara L, Hong, Sandy, Dedeoglu, Fatma, Torok, Kathryn S, Rabinovich, C Egla, Ferguson, Polly J, Punaro, Marilynn, Feldman, Brian M, Andrews, Tracy, Higgins, Gloria C

“…We designed and initiated a pilot comparative effectiveness study for juvenile localized scleroderma (jLS), for which there is limited evidence on best…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis by Ringold, Sarah, Angeles‐Han, Sheila T., Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis by Ringold, Sarah, Angeles‐Han, Sheila T., Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or…”
Get full text

Pediatric Neuro-Behçet's Disease Responsive to Adalimumab by Robinson, Angela Byun, MD, Gallentine, William B., DO, Rabinovich, C. Egla, MD, MPH

“…Neurologic manifestations of Behçet's disease (neuro-Behçet's disease) are uncommon, but may cause patients significant morbidity and mortality. Neuro-Behçet's…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis by Angeles‐Han, Sheila T., Ringold, Sarah, Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Holland, Gary N., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Sen, H. Nida, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Methods…”
Get full text

Pulmonary Manifestations of Rheumatic Diseases in Children by Buckley, Mary M., Rabinovich, C. Egla

“…Children with rheumatic disease have rare pulmonary manifestations that may cause significant morbidity and mortality. These children are often clinically…”
Get full text

Preliminary Evidence on Abatacept Safety and Efficacy in Refractory Juvenile Localized Scleroderma by Li, Suzanne C, Torok, Kathryn S, Ishaq, Sarah S, Buckley, Mary, Edelheit, Barbara, Ede, Kaleo C, Liu, Christopher, Rabinovich, C Egla

“…To evaluate the safety and efficacy of abatacept treatment for refractory juvenile localized scleroderma (jLS) in a retrospective study. A multicentre cohort…”
Get full text

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma by Li, Suzanne C, Higgins, Gloria C, Chen, Mallory, Torok, Kathryn S, Rabinovich, C Egla, Stewart, Katie, Laxer, Ronald M, Pope, Elena, Haines, Kathleen A, Punaro, Marilynn, O'Neil, Kathleen M

“…The aim of this study was to evaluate factors associated with extracutaneous involvement (ECI) in juvenile localized scleroderma (jLS). A prospective,…”
Get full text

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles‐Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein‐Gitelman, Marisa, Barbar‐Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie‐Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

“…Objective To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis,…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis by Angeles‐Han, Sheila T., Ringold, Sarah, Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Holland, Gary N., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Sen, H. Nida, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Methods…”
Get full text

Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study by Brunner, Hermine I., Pacheco-Tena, César, Louw, Ingrid, Vega-Cornejo, Gabriel, Alexeeva, Ekaterina, Appenzeller, Simone, Chasnyk, Vyacheslav, Griffin, Thomas, Suarez, Carmen Navarrete, Knupp-Oliveira, Sheila, Zeft, Andrew, Aviel, Yonatan Butbul, De Ranieri, Deirdre, Gottlieb, Beth S., Levy, Deborah M., Rabinovich, C. Egla, Silva, Clóvis Artur, Spivakovsky, Yury, Uziel, Yosef, Ringold, Sarah, Xu, Xie L., Leu, Jocelyn H., Lam, Edwin, Wang, Yuhua, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino

“…Objective To report pharmacokinetics (PK), immunogenicity, clinical effect, and safety of intravenous (IV) golimumab in children with active…”
Get full text